secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2022-02-14T23:59:59+00:00
Accession:  0000950170-22-001213
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medpace Q4 revenue up 18.8% to $308.6M; full year revenue +23.4%; Board approves $300M buyback increase
--------------------------------------------------------------------------------

- Q4 2021 GAAP net income $50.0M ($1.32 EPS) vs $50.9M ($1.35 EPS) prior year; net income margin 16.2%.
- Full year 2021 GAAP net income $181.8M ($4.81 EPS) vs $145.4M ($3.84 EPS); net income margin 15.9%.
- Net new business awards Q4 $458.7M (book-to-bill 1.49x), up 27.9% YoY; backlog $1,997.1M (+29.5%).
- EBITDA Q4 $61.4M (19.9% margin) vs $60.2M (23.2%) prior year; full year EBITDA $223.1M (19.5% margin).
- Board increased stock repurchase program by $300 million; program has no set expiration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022001213/0000950170-22-001213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022001213/medp-20220210.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-001213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer